The soluble form of human respiratory syncytial virus attachment protein differs from the membrane-bound form in its oligomeric state but is still capable of binding to cell surface proteoglycans

被引:37
作者
Escribano-Romero, E [1 ]
Rawling, J [1 ]
García-Barreno, B [1 ]
Melero, JA [1 ]
机构
[1] Inst Salud Carlos III, Ctr Nacl Microbiol, Madrid 28220, Spain
关键词
D O I
10.1128/JVI.78.7.3524-3532.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The soluble (Gs) and membrane-bound (Gm) forms of human respiratory syncytial virus (HRSV) attachment protein were purified by immunoafnity chromatography from cultures of HEp-2 cells infected with vaccinia virus recombinants expressing either protein. Sucrose gradient centrifugation indicated that Gs, which is secreted into the culture medium, remains monomeric, whereas Gm is an oligomer, probably a homotetramer. Nevertheless, Gs was capable of binding to the surface of cells in vitro, as assessed by a flow cytometry-based binding assay. The attachment of Gs to cells was inhibited by previous heparinase treatment of living cells, and Gs did not bind to CHO cell mutants defective in proteoglycan biosynthesis. Thus, Gs, as previously reported for the G protein of intact virions, binds to glycosaminoglycans presented at the cell surface as proteoglycans. Deletion of a previously reported heparin binding domain from Gs protein substantially inhibited its ability to bind to cells, but the remaining level of binding was still sensitive to heparinase treatment, suggesting that other regions of the Gs molecule may contribute to attachment to proteoglycans. The significance of these results for HRSV infection is discussed.
引用
收藏
页码:3524 / 3532
页数:9
相关论文
共 38 条
[1]  
Bembridge GP, 1998, J IMMUNOL, V161, P2473
[2]   SELECTION OF RECOMBINANT VACCINIA VIRUSES ON THE BASIS OF PLAQUE-FORMATION [J].
BLASCO, R ;
MOSS, B .
GENE, 1995, 158 (02) :157-162
[3]   EXTRACELLULAR VACCINIA VIRUS FORMATION AND CELL-TO-CELL VIRUS TRANSMISSION ARE PREVENTED BY DELETION OF THE GENE ENCODING THE 37,000-DALTON OUTER ENVELOPE PROTEIN [J].
BLASCO, R ;
MOSS, B .
JOURNAL OF VIROLOGY, 1991, 65 (11) :5910-5920
[4]   Pathogenesis of RSV lower respiratory tract infection: implications for vaccine development [J].
Brandenburg, AH ;
Neijens, HJ ;
Osterhaus, ADME .
VACCINE, 2001, 19 (20-22) :2769-2782
[5]   OLIGOMERIZATION AND POSTTRANSLATIONAL PROCESSING OF GLYCOPROTEIN-G OF HUMAN RESPIRATORY SYNCYTIAL VIRUS - ALTERED O-GLYCOSYLATION IN THE PRESENCE OF BREFELDIN-A [J].
COLLINS, PL ;
MOTTET, G .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :849-863
[6]  
Collins PL., 2001, FIELDS VIROLOGY, P1443
[7]  
Crennell S, 2000, NAT STRUCT BIOL, V7, P1068
[8]   Solution structure of the immunodominant region of protein G of bovine respiratory syncytial virus [J].
Doreleijers, JF ;
Langedijk, JPM ;
Hard, K ;
Boelens, R ;
Rullmann, JAC ;
Schaaper, WM ;
vanOirschot, JT ;
Kaptein, R .
BIOCHEMISTRY, 1996, 35 (47) :14684-14688
[9]   ANIMAL-CELL MUTANTS DEFECTIVE IN GLYCOSAMINOGLYCAN BIOSYNTHESIS [J].
ESKO, JD ;
STEWART, TE ;
TAYLOR, WH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (10) :3197-3201
[10]   Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G [J].
Feldman, SA ;
Hendry, RM ;
Beeler, JA .
JOURNAL OF VIROLOGY, 1999, 73 (08) :6610-6617